BioReference will broaden availability of serological antibody tests to states, hospitals and healthcare organizations throughout the United States ELMWOOD PARK, N.J., April 29, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing […]
Tag Archives: bioreference
BioReference Laboratories is the largest full service specialty laboratory in the United States that gives healthcare providers and patients the information to make confident healthcare decisions.
28
Apr
Apr
Sexually transmitted infections or STIs, also referred to as sexually transmitted diseases or STDs, are common in men and women. April is STD/STI Awareness Month, so there is no time like the present to talk with your sexual partner(s) and get tested. Did You Know? There are approximately 20 million new STI cases each year […]
21
Apr
Apr
It is Medical Laboratory Professionals Week – the annual celebration of the medical laboratory professionals and pathologists who play a vital role in health care and patient advocacy. This year, in the midst of the COVID-19 pandemic, lab professionals around the world have been working extremely hard and deserve special recognition. What is Medical Laboratory […]
Press Release
OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)
06
Apr
Apr
ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]
Press Release
OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
24
Mar
Mar
BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]
Press Release
OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test
05
Mar
Mar
COVID-19 test will aid healthcare professionals and public health authorities to identify patients infected with COVID-19 ELMWOOD PARK, N.J., March 05, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will offer a test for the novel coronavirus (2019-nCoV), a contagious virus that causes respiratory infection and has shown evidence of human-to-human […]
17
May
May
BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).
MIAMI, FL NOVEMBER 8, 2018 — BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory in the United States, will remain an in-network provider with Horizon Health Services, Inc. (Horizon), New Jersey’s oldest and largest health insurer. After an extensive evaluation of its laboratory network, BRL will remain a preferred laboratory in the Horizon PPO network. The […]